文献速递膀胱癌与上尿路尿路上皮癌泌尿系感染

膀胱癌BCG灌注后卡介苗感染的发生率与死亡率

Incidence of and mortality from Bacille Calmette-Guérin (BCG) infections after BCG instillation therapy.
PubMed 文献 · BJU Int · 2021-10-25

芬兰全国性登记研究纳入1996至2016年膀胱癌BCG灌注治疗患者,识别87例BCG感染,研究后期累积发生率比例升至2.5%,总体死亡率10%,全身性感染死亡率17.5%,显著高于既往报道。

要点

  • BCG灌注后感染累积发生率达2.5%,呈逐渐上升趋势。
  • BCG感染总体死亡率10%,全身性感染死亡率17.5%。
  • 该死亡率显著高于既往文献报道,需提高警惕。

核心结论

  • 芬兰膀胱癌BCG灌注患者中BCG感染发生率比例升至全国水平2.5%,死亡率显著高于既往报道。

研究设计与样本

  • 全国性登记研究,利用芬兰癌症登记处和芬兰国家传染病登记处识别1996至2016年BCG感染患者,基于全国 consumed BCG doses 估算治疗人数,并详细病历回顾描述临床特征与结局。

主要发现

  • 共识别87例膀胱癌BCG治疗后BCG感染患者。
  • 发生率比例逐渐增加,研究后半期累积发生率比例为2.5%。
  • BCG感染导致显著死亡,总体死亡率10%,全身性感染死亡率17.5%。

关键数值与推荐

  • 累积发生率比例2.5%(研究后半期,全国水平)。
  • 总体死亡率10%,全身性感染死亡率17.5%。

临床怎么用

  • 临床应警惕BCG灌注后感染风险,尤其全身性感染,需早期识别和干预以降低死亡风险。

局限性

  • 基于登记数据估算治疗人数,可能存在未完全捕获的BCG感染病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the incidence of and mortality associated with Bacille Calmette-Guérin (BCG) infections in a Finnish population of patients with bladder cancer treated with BCG instillations. MATERIALS AND METHODS: We conducted a nationwide register study and identified patients with BCG infections in Finland during 1996 to 2016 using the Finnish Cancer Registry and the Finnish National Infectious Diseases Register. We estimated the number of patients treated with BCG instillations based on data on national consumed BCG doses used to treat patients with bladder cancer, and calculated the annual incidence proportion of BCG infections. We further performed a detailed medical chart review to describe the clinical features and outcomes of the treated BCG infections. RESULTS: In total, 87 patients with BCG infection after BCG treatment of bladder cancer were identified. The incidence proportion increased gradually, yielding a cumulative incidence proportion of 2.5% during the latter half of the study period. BCG infections led to significant mortality, with 10% overall mortality and 17.5% mortality from systemic infections, which is notably higher than previously reported. CONCLUSION: The incidence proportion of BCG infections among bladder cancer patients treated with BCG has increased in Finland up to 2.5% at a nationwide level, with a notably higher mortality rate than previously reported.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Nurminen P, Ettala O, Uusitalo-Seppälä R, et al. Incidence of and mortality from Bacille Calmette-Guérin (BCG) infections after BCG instillation therapy. BJU Int. 2021. PMID: 34617382. doi:10.1111/bju.15608

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。